Abstract Postpartum hemorrhage (PPH) is the leading cause of maternal mortality worldwide. However, the mechanism underlying atonic PPH remains partially elucidated. Multi-omics revealed that differentially expressed proteins and metabolites were enriched in the immune-inflammation pathway in the vaginal blood of patients with atonic PPH. There was a pro-inflammatory immune microenvironment primarily activated by M1 macrophages in the decidua of the patients with atonic PPH, which presented as increased tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-8 levels and affected the contraction of the uterine smooth muscle. Besides, the decidual macrophage of the atonic PPH group exhibited increased oxidative stress. The PPH decidual cell culture medium induced the polarization of peripheral blood monocytes towards M1 macrophages while markedly increasing the levels of reactive oxygen species and superoxide anion radical. Using hydrogen peroxide (H[2]O[2]) to stimulate decidual macrophages induced a similar polarization state to that in atonic PPH samples, and the secretion of pro-inflammatory cytokines, such as TNF-α and IL-8, was significantly upregulated, which markedly impacted the expression of contraction-associated proteins (CAPs) in the uterine smooth muscle cells (uSMCs). The animal model suggested that H[2]O[2] promoted the polarization of placental macrophages towards M1, affecting the levels of placental oxidative stress and inflammatory infiltration, and the contractility of uterine smooth muscle tissues. In summary, abnormal oxidative stress at the maternal-fetal interface induced the M1 polarization of decidual macrophages, causing the secretion of pro-inflammatory cytokines. TNF-α and IL-8 acted on uSMCs to inhibit CAP expression, inducing atonic PPH. Keywords: Atonic postpartum hemorrhage, Macrophage polarization, Oxidative stress, Cytokines, Uterine contraction-associated proteins 1. Introduction Postpartum hemorrhage (PPH) is a common complication in obstetrics and is defined as blood loss exceeding 500 mL within 24 h of vaginal delivery [[37]1]. PPH is the leading cause of pregnancy-related deaths and accounts for approximately a quarter of maternal deaths [[38]2,[39]3], which is correlated with the occurrence of adverse clinical outcomes [[40]1]. Uterine atony is the most common cause of PPH (approximately 70 %) [[41]4]. However, low-risk pregnant women experience atonic PPH in clinical settings. The vague mechanism and unpredictability of PPH cause delayed treatment and an increased risk of adverse clinical outcomes. Therefore, elucidating the mechanism of atonic PPH is crucial for identifying effective treatment measures. As the uterus remodels in preparation for delivery, the excitability and contractility of the uterine smooth muscle layer, the myometrium, increases drastically [[42]5]. At term, the increased secretion of pro-inflammatory cytokines (interleukin (IL)-8, tumor necrosis factor (TNF)-α, IL-1β, and IL-6) promote increased expression of cyclooxygenase-2 (COX-2) and oxytocin receptor (OTR) in myometrium; this results into strong and frequent uterine contractions, which subsequently promote the onset of labor [[43]6]. The immune-inflammatory reaction at the maternal–fetal interface is crucial in this process, with decidual immune cells playing a crucial role in regulating the process. Decidual macrophages are the second largest immune cells at the maternal-fetal interface, accounting for 10–20 % [[44]7]. Decidual macrophages transform into a pro-inflammatory phenotype at the onset of labor, inducing myometrium contraction and labor initiation [[45]8]. Simultaneously, the levels of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β, and C C motif ligand 2 (CCL-2) are positively correlated with uterine contractility [[46][9], [47][10], [48][11], [49][12], [50][13]]. However, some studies revealed that prolonged exposure to pro-inflammatory cytokines, including TNF-α and IL-1, could cause impaired oxytocin signaling and depletion of calcium ions in muscle cells, affecting uterine muscle contraction [[51]10,[52]11]. This suggested that excessive activation of immune-inflammatory responses might inhibit myometrium contraction. Previous studies demonstrated that the levels of immune-inflammatory factors, such as IL-1β, IL-18, macrophage inflammatory protein (MIP)-1α, IL-6, and monocyte chemotactic protein (MCP)-1, in the peripheral blood of pregnant women before delivery, who had atonic PPH, were significantly higher than those in the control group [[53]4,[54]14]. Consequently, the abnormal pro-inflammatory phenotype of decidual macrophages might affect the contractile function of uterine smooth muscle cells (uSMCs). The uterine blood flow at term pregnancy can be as high as 1300 ml/min. When the myometrium cannot contract in a strong and sustained manner, it fails to timely compress the spiral arteries that supply the placental bed, resulting in a rapid hemorrhage from the placental bed, culminating in the occurrence of PPH [[55]15]. Previous studies have shown that the macrophage phenotype was closely related to their oxidative stress state. Mitochondrial damage and the release of excess oxidative substances, such as reactive oxygen species (ROS), were crucial for the release of pro-inflammatory cytokines in monocytes and macrophages [[56]16]. Therefore, we aimed to investigate the relationship between immune-inflammatory and oxidative stress states in decidual macrophages at the maternal-fetal interface in atonic PPH. Similarly, we combined omics and multiplex Luminex assays to validate the promotion of M1 macrophage polarization and pro-inflammatory cytokine release through an abnormal oxidative stress state in decidual macrophages and the regulation of uSMC contraction to reveal the potential mechanism of atonic PPH which was confirmed through in vitro cell experiments and rat models. 2. Materials and methods 2.1. Inclusion criteria of clinical sample This was a nested case-control study on a prospective cohort of pregnant women who underwent regular prenatal checkups at Peking University's Third Hospital between December 2022 and December 2023. The inclusion criteria were natural conception, full-term pregnancy, and single pregnancy through vaginal delivery. The exclusion criteria were PPH secondary to definite causes (such as placenta accreta, soft birth canal lacerations, underlying coagulation disorder, previous autoimmune diseases, and recent acute and chronic intrauterine or systemic infections), obstetric complications (including preeclampsia and gestational diabetes mellitus (GDM) other than type A1), and uterine atony with definite causes (such as macrosomia, multiple pregnancies, and precipitous deliveries). Following the above criteria, 30 pregnant women with PPH were included. The control (non-PPH) group was matched with baseline information (including maternal age, gestational age, and pregnancy complications, such as hypertensive disorders in pregnancy [HDP] and GDM) without PPH. All procedures were approved by the Medical Science Research Ethics Committee of Peking University Third Hospital (M2021685). 2.2. Clinical sample collection Upon entering the first stage of labor (the interval between the onset of labor and complete or 10 cm cervical dilation), 5 mL of peripheral blood was collected in an Ethylenediaminetetaracetic acid (EDTA) tube. At the end of the third stage of labor, after placenta delivery, 5 mL of vaginal blood was collected in an EDTA tube. Both blood samples were centrifuged at 12,000×g and 4 °C for 10 min and stored at −80 °C. Following the delivery of the placenta, 3 × 3 × 1 cm decidua and placental tissue were sectioned and fixed in 10 % neutral formalin. Subsequently, 5–10 g of decidua was scraped from the maternal surface of the placenta and washed with phosphate-buffered saline. The decidua tissue was then cut and digested in 100U/mL collagenase Ⅱ and Ⅳ, and 100U/mL DNAase and placed on a constant temperature shaker at 37 °C for 40 min. The tissue was then ground on a 100 μm sieve. The resultant cell suspension was collected and then centrifuged at 1500 rpm for 5 min. After discarding the supernatant, 3–5 mL of ACK red blood cell (RBC) lysis buffer was added to lyse RBC at 4 °C for 10 min, and upon completion of lysis, 40 mL phosphate buffer saline (PBS) was added to terminate the process. After the decidual cells were centrifuged at 1500 rpm for 5 min, they were collected into 24-well plates at 3 × 10^6 cells per well for 24 h and centrifuged at 1500 rpm for 5 min. Finally, the supernatant, namely, the decidual cells culture medium, was collected. Decidua samples were collected from women with normal vaginal delivery, and flow cytometry was used to select CD14+macrophages from the decidua. The decidual tissue was digested to extract decidual macrophages, and RBCs were lysed as described above, with the resultant cell suspension being collected for subsequent analysis. Flow cytometry was performed in a 100 μL system with 1 μL of CD14-APC antibody/2 ∗ 10^6 cells for 20 min. The sorted cells were resuspended in a Dulbecco's Modified Eagle Medium (DMEM, Gibco, CAT: C11995500BT) containing 2 mmol/L glutamine and 25 ng/mL granulocyte-macrophage colony stimulating factor (GM-CSF) and collected in 48-well plates, specifically at 3.5∗10^5 cells per well. 2.3. Flow cytometry 2.3.1. Treatment of cells The decidua samples from control group (CTRL) and atonic PPH patients were collected and processed as outlined in the section Clinical sample collection. Decidual cells were sorted, including macrophages, natural killer (NK) cells, and T lymphocytes (T cells) from the atonic PPH and CTRL groups. Peripheral blood samples were collected from women with normal vaginal delivery during labor and centrifuged at 12,000×g for 10 min. The white membrane layer, including peripheral blood mononuclear cells, were collected through centrifugation with 3 mL of Ficol added. After being labeled with CD14 magnetic beads, CD14^+ monocytes were sorted using the Meitianni fully automatic magnetic bead sorter and then plated and cultured in 48-well plates at 4 × 10^5 cells per well for 24 h. The culture media were replaced with CTRL- or PPH-patient-derived decidual cells culture medium as outlined in the section Clinical sample collection. CD14+monocytes were further cultured for 48 h, and after centrifugation at 500×g for 5 min, the CD14+monocytes were collected for subsequent analysis. Decidua samples were collected from women with normal vaginal delivery, and flow cytometry was used to select CD14+macrophages from the decidua, which was described comprehensively in the section Clinical sample collection. Decidual CD14^+ macrophages were plated and cultured in 48-well plates at 3.5 × 10^5 cells per well for 24 h, and 0, 1, 10, and 100 μmol/L of H[2]O[2] were added for 1 h or cultured in the CTRL- or PPH-patient-derived decidual cell culture media for 48 h, followed by centrifugation at 500×g for 5 min. Finally, CD14+monocytes were collected for subsequent analysis. 2.3.2. Analyses The decidual cells, including macrophages, NK cells, and T cells, were stained for 30 min at 25 °C in the dark. The following antibodies were used: Brilliant Violet 421 anti-human CD45 (Biolegend, CAT: 304032, dilution: 1:200), APC anti-human CD14 (Biolegend, CAT: 325608, dilution: 1:200), PE/Cyanine5 anti-human CD3 (Biolegend, CAT: 317355, dilution: 1:200), FITC anti-human CD56 (Biolegend, CAT: 362546, dilution: 1:200), and Mito SOX (Thermo, CAT: [57]M36008, dilution: 1:500). The samples were then centrifuged at 1500×g for 5 min, washed and resuspended in 300–400 μL PBS. Finally, the cells were then immediately analyzed using a Canto flow cytometer (Beckman Counter FACS Galios). The CD14^+ monocytes from peripheral blood samples were stained for 30 min at 25 °C in the dark. The following dyes were used: Mito SOX (Invitrogen, CAT: M36007, dilution: 1:2500) and DCFH-DA (Solarbio, CAT: D6470, dilution: 1:500). A SONY ID7000 full-spectrum flow cytometer was used to detect fluorescence. The CD14^+ macrophages from decidual samples were stained for 1 h at 4 °C with 50 μL of staining system. The following antibodies were used: CD206 (Biolegend, CAT: 321131, dilution: 1:200) and CD86 (Biolegend, CAT: 374216, dilution: 1:200). Finally, upon completion of staining, the cells were immediately analyzed using a Beckman Cytoflex flow cytometer. 2.4. Vaginal proteomics The vaginal blood was centrifuged at 12,000×g and 4 °C for 10 min. Subsequently, 50 μL of blood samples were incubated in magnetic nanomaterials (PTM-00F13303, PTM Bio) at 1200×g and 37 °C for 1 h, and magnetic beads were washed thrice. Next, 70 μL of enzymatic hydrolysis buffer (200 mM Tris,pH8.0) was added, followed by heating at 95 °C for 10 min. After the sample dropped to 25 °C, 20 ng/μL trypsin was added for hydrolysis overnight at 37 °C. To achieve a final concentration of 5 mM, reduction was performed at 56 °C for 30 min using 1 M dithiothreitol. Furthermore, 550 mM iodoacetamide was added to achieve a final concentration of 11 mM. According to the C18 ZipTips manual, salt was removed, and vacuum-freezing was conducted, followed by drying and liquid chromatography-mass spectrometry. After enzymatic hydrolysis, the peptide segments were acidified with 10 % trifluoroacetic acid to attain pH 2–3 and centrifuged at 12,000×g for 10 min at 25 °C, and the supernatant was collected. Similarly, 50 μL of activation solution, desalination solution, peptide segment, and desalination solution were added to StageTip sequentially, centrifuged at 1500×g per step for 1 min, and repeated once. Finally, 20 μL of eluent was added, followed by centrifugation at 750×g for 1 min, freezing, spin-drying, and setting aside for later use. The peptide segments were dissolved in liquid chromatography mobile phase A and separated using an EASY nLC 1200 ultra-high-performance liquid chromatography system. For ionization, the samples were injected into an NSI ion source and analyzed using an Orbitrap Exploris 480 mass spectrometer. Data were collected using a data-independent scanning program. The intensity (I) of proteins in different samples was normalized through a centralization transformation to obtain the relative quantitative values (R) in different samples. To evaluate the quantitative reproducibility between biological or technological replicates, repeatability was analyzed using three statistical methods, namely Pearson's correlation coefficient, principal component analysis (PCA), and relative standard deviation (RSD). 2.5. Vaginal blood metabolomics To 20 % acetonitrile methanol internal standard extraction solution, 50 μL of the sample was added, vortexed for 3 min, and centrifuged at 12,000×g and 4 °C for 10 min. The supernatant was stood at −20 °C for 30 min, centrifuged at 12,000×g and 4 °C for 3 min, and transferred for analysis on the machine. Raw data were extracted and corrected using the XCMS program in mzXML format. Metabolite identification was performed by searching the laboratory's in-house database and integrating public and prediction databases, and metDNA methods. Finally, substances with a comprehensive identification score of ≥0.5 and a QC sample CV of <0.3 were extracted, and the positive and negative modes were merged to obtain metabolite data. We conducted quality control analysis, PCA, cluster analysis, grouped principal component analysis, orthogonal partial least squares discriminant analysis, dynamic distribution of metabolite content differences, and screening of differential metabolites. Metabolites with a variable importance in the projection (VIP) of >1 (Student's t-test, P < 0.05) were further analyzed. A higher VIP value indicated that a metabolite played a more prominent role in distinguishing between different groups or in explaining experimental variables. These metabolites may help elucidate or distinguish the differences between the groups effectively. In differential metabolite analysis, the Kyoto Encyclopedia of the Genome (KEGG), Human Metabolome Database (HMDB), and MebaboAnalyst databases were used for KEGG, HMDB, and MSEA functional annotation and enrichment analyses, respectively. 2.6. Proteomic and metabolomic analysis Firstly, statistical analysis of differential proteins and metabolites was conducted. Specifically, the differential screening criteria for proteins were FC > 1.5 or FC < 1/1.5 and P < 0.05, whereas that for metabolites were | log2FC |>0, P < 0.05, and VIP>1. iPath analysis tools were used to simultaneously map differentially expressed proteins and metabolites to the iPath pathway map, obtain their shared pathway information, screen for pathways with both differential proteins and metabolites, and finally visualize them. Using the resultant quantitative outputs, the Spearman correlation analysis was performed on differentially expressed proteins and metabolites to screen for those that exhibited a significant correlation (correlation coefficient |r |≥0.8) and construct their co-expression relationship network. Finally, the Metscape plugin in Cytoscape was used to construct a network of differentially expressed proteins and metabolites. This network was built based on secondary data from various sources (i.e., databases, experiments, etc.), delving into the relationship between metabolites and proteins. The compound network was visualized it displayed information on compound structures, reaction types, enzymes, genes, and pathways, while also being able to validate differential proteins at a metabolic level closer to phenotype. The above analysis combined methods commonly used in omics, including (1) association analysis based on statistical methods, (2) association analysis based on metabolic pathway analysis, (3) association analysis based on interaction, and (4) correlation analysis based on references and